This trial is being conducted in pediatric patients with Hypothalamic Obesity. This generally
occurs in people who have had an injury to or tumor in their hypothalamus (gland or organ
that secretes hormones). The purpose of this trial is to see how an investigational treatment
controls the hormone insulin by lowering the level of insulin in the body resulting in a
weight loss in children who are at least 6 years of age but less than 18 years of age. Some
children in this trial will receive placebo.
To qualify for this study, you and your child's doctor must feel that your child's weight is
inadequately controlled within a year from the time of injury to the hypothalamus or tumor of
the hypothalamus. This study will help to determine if an investigational treatment is of
benefit in controlling a child's weight.